Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al - Bin Zhang; Jieling Zheng (Journal for ImmunoTherapy of Cancer)